{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:42Z","timestamp":1707525282431},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,24]]},"DOI":"10.7759\/cureus.45877","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:50:57Z","timestamp":1695621057000},"source":"Crossref","is-referenced-by-count":0,"title":["Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma"],"prefix":"10.7759","author":[{"given":"Xiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Gaibor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Fesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga AR","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, et al.. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022, 21:176-88. 10.1016\/S1474-4422(21)00297-0","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.07.030","article-title":"An update on laboratory diagnosis in myasthenia gravis","volume":"449","author":"Oger J","year":"2015","unstructured":"Oger J, Frykman H. An update on laboratory diagnosis in myasthenia gravis. Clin Chim Acta. 2015, 449:43-8. 10.1016\/j.cca.2015.07.030","journal-title":"Clin Chim Acta"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami P","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, et al.. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021, 96:114-22. 10.1212\/WNL.0000000000011124","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.2.624","article-title":"Myasthenia gravis associated with small-cell carcinoma of the lung","volume":"105","author":"Fujita J","year":"1994","unstructured":"Fujita J, Yamadori I, Yamaji Y, Yamagishi Y, Takigawa K, Takahara J. Myasthenia gravis associated with small-cell carcinoma of the lung. Chest. 1994, 105:624-5. 10.1378\/chest.105.2.624","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.615426","article-title":"Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature","volume":"53","author":"Rezania K","year":"2012","unstructured":"Rezania K, Soliven B, Baron J, Lin H, Penumalli V, van Besien K. Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leuk Lymphoma. 2012, 53:371-80. 10.3109\/10428194.2011.615426","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.5.1019","article-title":"Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy","volume":"45","author":"Abrey LE","year":"1995","unstructured":"Abrey LE. Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy. Neurology. 1995, 45:1019. 10.1212\/wnl.45.5.1019","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-5676-1","article-title":"Primary CNS lymphoma in myasthenic on long-term azathioprine","volume":"74","author":"Finelli PF","year":"2005","unstructured":"Finelli PF. Primary CNS lymphoma in myasthenic on long-term azathioprine. J Neurooncol. 2005, 74:91-2. 10.1007\/s11060-004-5676-1","journal-title":"J Neurooncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199012203232510","article-title":"Cancers complicating organ transplantation","volume":"323","author":"Penn I","year":"1990","unstructured":"Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990, 323:1767-9. 10.1056\/NEJM199012203232510","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000173031.56429.04","article-title":"Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil","volume":"65","author":"Vernino S","year":"2005","unstructured":"Vernino S, Salomao DR, Habermann TM, O'Neill BP. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology. 2005, 65:639-41. 10.1212\/01.wnl.0000173031.56429.04","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184414-killing-two-birds-with-one-stone-successful-management-with-rituximab-in-the-coexistence-of-myasthenia-gravis-and-marginal-zone-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:55Z","timestamp":1707509215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184414-killing-two-birds-with-one-stone-successful-management-with-rituximab-in-the-coexistence-of-myasthenia-gravis-and-marginal-zone-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,24]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.45877","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,24]]}}}